References
- Lancet v.2 no.8000 Selective loss of central cholinergic neurons in Alzheimer's disease Davies P;Maloney AJ
- Lancet v.1 no.8004 Necropsy evidence of central cholinergic deficits in senile dementia Perry EK;Perry RH;Blessed G;Tomlinson BE
- J Neurol Sci. v.57 no.2-3 Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients Bowen DM;Benton JS;Spillane JA;Smith CC;Allen SJ
- Science v.217 no.4558 The cholinergic hypothesis of geriatric memory dysfunction Bartus RT;Dean RL 3rd;Beer B;Lippa AS
- Arch Neurol v.36 no.8 Effect of physostigmine on constructional and memory tasks in Alzheimer's disease Muramoto O;Sugishita M;Sugita H;Toyokura Y
- Mol Pharmacol v.57 no.2 Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease Camps P;Cusack B;Mallender WD;El Achab RE;Morral J;Munoz-Torrero D;Rosenberry TL
- Kor. J. Pharmacogn v.28 no.4 Screening of the acetylcholinesterase inhibitors from medical plants Lee BH;Choi BW;Ryu GS;Lee ES;Kang KJ;Hwang DY;Hong ND
- Dev Boil. v.76 no.1 The effects of nerve growth factor on acetylcholinesterase and its multiple forms in cultures of rat PC12 pheochromocytoma cells: increased total specific activity and appearance of the 16 S molecular form Rieger F;Shelanski ML;Greene LA
- Biochem Pharmacol v.7 A new and rapid colorimetric determination of acetylcholinesterase activity Ellman GL;Courtney KD;Valentino A;Feather-stone RM
- J Biochem Toxicol v.11 no.6 Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos Mortensen SR;Chanda SM;Hooper MJ;Padilla S
- Mol Cells v.11 no.2 Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase Chung YK;Heo HJ;Kim EK;Kim HK;Huh TL;Lim Y;Kim SK;Shin DH
- Lancet v.2 no.8000 Selective loss of central cholinergic neurons in Alzheimer's disease Davies P;Maloney AJ
- Lancet v.1 no.8004 Necropsy evidence of central cholinergic deficits in senile dementia Perry EK;Perry RH;Blessed G;Tomlinson BE
- J Neurol Sci. v.57 no.2-3 Choline acetyltransferase activity and histopathology of frontal neocortex from biopsies of demented patients Bowen DM;Benton JS;Spillane JA;Smith CC;Allen SJ
- Science v.217 no.4558 The cholinergic hypothesis of geriatric memory dysfunction Bartus RT;Dean RL 3rd;Beer B;Lippa AS
- Arch Neurol. v.36 no.8 Effect of physostigmine on constructional and memory tasks in Alzheimer's disease Muramoto O;Sugishita M;Sugita H;Toyokura Y
- Mol Pharmacol. v.57 no.2 Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease Camps P;Cusack B;Mallender WD;El Achab RE;Morral J;Munoz-Torrero D;Rosenberry TL
- Kor. J. Pharmacogn. v.28 no.4 Screening of the acetylcholinesterase inhibitors from medical plants Lee BH;Choi BW;Ryu GS;Lee ES;Kang KJ;Hwang DY;Hong ND
- Dev Boil. v.76 no.1 The effects of nerve growth factor on acetylcholinesterase and its multiple forms in cultures of rat PC12 pheochromocytoma cells: increased total specific activity and appearance of the 16S molecular form Rieger F;Shelanski ML;Greene LA
- Biochem Pharmacol. v.7 A new and rapid colorimetric determination of acetylcholinesterase activity Ellman GL;Courtney D;Valentino A;Featherstone RM
- J Biochem Toxicol. v.11 no.6 Maturational differences in chlorpyrifos-oxonase activity may contribute to age-related sensitivity to chlorpyrifos Mortensen SR;Chanda SM;Hooper MJ;Padilla S
- Mol Cells v.11 no.2 Inhibitory effect of ursolic acid purified from Origanum majorana L on the acetylcholinesterase Chung YK;Heo HJ;Kim EK;Kim HK;Huh TL;Lim Y;Kim SK;Shin DH